Massachusetts
Who we are
GCC19CART for Patients With Metastatic Colorectal Cancer
A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas
Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone in Participants With Resected Solid Tumors and in Combination With Pembrolizumab in Participants With Unresectable Solid Tumors
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers
Dabrafenib + Trametinib + PDR001 In Colorectal Cancer
Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & Neck
Pembrolizumab and Recombinant Interleukin-12 in Treating Patients With Solid Tumors
A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors
